The Minister of Health is striving to provide Polish patients with access to Paxlovid. Talks on this issue have been held for some time, including at the European Union level, the Communication Office of the Ministry of Health informed PAP.
The European Medicines Agency (EMA) recommended the granting of a conditional marketing authorization for the oral antiviral drug Paxlovid for the treatment of COVID-19 in late January. The applicant is the concern Pfizer. The EMA has recommended a marketing authorization for Paxlovid for adults who do not require supplemental oxygen and are at increased risk.
- A new drug for COVID-19. Virologist: very good efficacy
«The Minister of Health aims to provide Polish patients with access to Paxlovid. In connection with the above, talks have been held for some time, including at the European Union level, ”informed the Ministry of Health. The ministry made a reservation that it is not possible to provide more precise data at the current stage of the talks.
Paxlovid is the first orally administered antiviral drug recommended in the EU for the treatment of COVID-19. It contains two active substances, PF-07321332 and ritonavir, in two different tablets. PF-07321332 reduces the ability of SARS-CoV-2 (the virus that causes COVID-19) to multiply in the body, while ritonavir prolongs the effects of PF-07321332 by allowing it to stay in the body for longer at levels that help the virus to reproduce.
The EMA concluded that treatment with paxlovid significantly reduced the number of hospitalizations or deaths of patients with at least one underlying condition that put them at risk of severe COVID-19. The analysis was performed in patients who had received paxlovid or placebo (a dummy treatment) within five days after the onset of COVID-19 symptoms.
Most of the patients in the study were infected with the delta variant of the SARS-CoV-2 coronavirus. Based on laboratory studies, paxlovid is also expected to work against omicron and other variants, the EMA reported. (PAP)
Author: Agata Zbieg
Have you been infected with COVID-19 and are worried about the side effects? Check your health by performing a comprehensive test package for convalescents.
Read also:
- Denmark and UK without restrictions. These charts show the effect with what
- Omikron-party – they want to get infected and get COVID-19 “over the head”
- Do you have this blood type? There is less risk of catching COVID-19
The content of the medTvoiLokony website is intended to improve, not replace, the contact between the Website User and their doctor. The website is intended for informational and educational purposes only. Before following the specialist knowledge, in particular medical advice, contained on our Website, you must consult a doctor. The Administrator does not bear any consequences resulting from the use of information contained on the Website. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.